Lexicon Pharmaceuticals
LXRX
#6851
Rank
โ‚ฌ0.66 B
Marketcap
1,50ย โ‚ฌ
Share price
-4.55%
Change (1 day)
16.74%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -0,13ย โ‚ฌ

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,13ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,12ย โ‚ฌ an increase over its 2024 EPS that were of -0,57ย โ‚ฌ.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,13ย โ‚ฌ3.63%
2025-0,12ย โ‚ฌ-78.13%
2024-0,57ย โ‚ฌ-20%
2023-0,71ย โ‚ฌ31.15%
2022-0,54ย โ‚ฌ-0%
2021-0,54ย โ‚ฌ10.91%
2020-0,49ย โ‚ฌ-145.08%
20191,09ย โ‚ฌ-206.09%
2018-1,03ย โ‚ฌ-5.74%
2017-1,09ย โ‚ฌ-10.95%
2016-1,22ย โ‚ฌ2640%
2015-0,04462ย โ‚ฌ-96.34%
2014-1,22ย โ‚ฌ-2.53%
2013-1,25ย โ‚ฌ-9.09%
2012-1,37ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
16,62ย โ‚ฌ-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4,83ย โ‚ฌ-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
37,40ย โ‚ฌ-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-5,21ย โ‚ฌ 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
8,93ย โ‚ฌ-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01785ย โ‚ฌ-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-0,67ย โ‚ฌ 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
0,34ย โ‚ฌ-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,14ย โ‚ฌ 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA